Megan Egbert — Moved to approve the minutes, though the date was later corrected in discussion.
Megan Egbert — Representative Egbert first moves to send RS 33450 to the second reading calendar with a due pass recommendation. Later in the meeting, she asks whether the legislature can introduce bills to remove substances from the schedule and seeks confirmation that, if evidence supports it, legislation could be used to take substances off the schedule.
Steven Tanner — Representative Steven Tanner is introduced as the next agenda item and then speaks to identify himself as representing District 13 and to present RS 33-496 for introduction.
David Leavitt — Moved to introduce RS 33-496.
Dori Healey — Identified as the next senior member who will take the gavel.
Faye Thompson — The transcript says 'Representative Healy'; the expected member list includes Dori Healey, who is likely intended.
Marco Erickson — Identified himself as Representative Marco Erickson from District 33.
Marco Erickson — Presented House Bill 497 and explained the planned procedure.
Marco Erickson — Returned to present RS 33450.
Marco Erickson — Presented RS 33450 as the cleanup version of House Bill 497.
Jordan Redman — Moved to hold House Bill 497 in committee.
Jordan Redman — Representative Redman declares a Rule 80 due to his ownership of retail pharmacies, notes that there has been significant research on ibogaine, and says he would support legislation if introduced but will vote in favor of the docket to keep proceedings moving.
Robert Beiswenger — Representative Beiswenger discusses ibogaine’s Schedule I status, questioning whether there is research supporting its placement on the schedule and noting he has not found any. He says he would likely vote no because the research suggests medical benefit, explains that he has been looking into the issue, and argues that ibogaine should be removed from Schedule I to make it more available for treatment. Later remarks reference and respond to his comments about ibogaine research and scheduling.
Brandon Shippy — Called on to respond to the question about ibogaine's listing.
Brandon Shippy — Invites DOPL to answer the question further and introduces the witness.
Brandon Shippy — Says he is open to bringing the research forward as a future bill and working with Representative Beiswenger.
Brandon Shippy — Says the committee could bring the research forward as a future bill and work with Representative Beiswenger.
Brandon Shippy — Closes the agenda and returns the gavel after the motion carries.
Oren Duffin — Oren Duffin introduces himself as representing the Division of Occupational and Professional Licenses and the Idaho Board of Pharmacy. He explains that he has not personally reviewed the research but is open to examining it, and he confirms that the legislature has the authority to bring legislation to change scheduling.
Tanya Burgoyne — Mentioned as already having received the gift from prison industries.